Prostate Screenings: Importance and How to Prepare

Prostate screening is aimed at finding prostate cancer and other prostate problems earlier, when more options may be available. Whether and when to screen is an individualized decision made with a clinician, based on age, family history, ancestry, symptoms, and preferences.

Why screening is discussed

Prostate cancer often grows slowly and may cause few early symptoms. PSA blood testing and, when used, digital rectal examination (DRE) are the common screening tools. Early detection can change management for some men; screening can also lead to further tests and to treatment of cancers that would never have caused harm. That trade-off is why guidelines emphasize shared decision-making rather than a single age rule for everyone.

Types of prostate screening

Prostate-specific antigen (PSA) test

PSA is a blood test. Higher levels can be associated with prostate cancer, but also with benign prostatic enlargement, prostatitis, recent ejaculation, urinary procedures, and other factors. A single elevated value is not a cancer diagnosis. Interpretation depends on age, PSA trend, prostate size, and clinical context.

Digital rectal exam (DRE)

In a DRE, a clinician feels the prostate through the rectal wall for asymmetry, firmness, or nodules that warrant further evaluation. The exam is brief. It can be uncomfortable; it should not be severely painful. Abnormal findings need follow-up even when PSA is in a typical range, and the reverse is also true.

How to prepare

• Talk through risk and timing — family history of prostate cancer (especially relatives diagnosed young), African ancestry, prior PSA values, and urinary or sexual symptoms help set a plan.
• Ask what the visit will include — blood draw for PSA alone, PSA plus DRE, or referral pathways if results are abnormal.
• Follow pre-test instructions — some clinicians ask men to avoid ejaculation for 24–48 hours before PSA, and to mention recent urinary infection, catheterization, or prostate procedures, because those can raise PSA.
• Bring a medication list — including supplements; some drugs affect PSA or urinary symptoms.

After the screening

Results should be explained in context. Elevated PSA or an abnormal DRE may lead to repeat PSA, free-to-total PSA or other biomarkers, MRI, or biopsy. Many men with an abnormal screen do not have cancer. Conversely, a “normal” screen does not guarantee the absence of disease forever — ongoing decisions continue over time.

If prostate treatment becomes necessary later, sexual-function planning matters early. See Before Prostate Treatment: The Sexual-Function Questions to Ask and Supporting Sexual Function After Prostate Surgery.

If you have questions about anything in this article, write to us at hello@xialla.com. We read and answer every message.